Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 945 across all filing types
Latest filing 2024-08-01 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recordings of an earnings call conducted on August 1, 2024, for the quarter ended June 30, 2024. It provides a link to the audio recording but does not contain the transcript or detailed financial data itself. The document is short (1110 characters) and serves as an announcement or notification rather than the full earnings release or call transcript. According to the rules, announcements about earnings calls or their recordings are best classified as Regulatory Filings (RNS) since it does not contain the full transcript or financial highlights. Therefore, the appropriate classification is RNS with high confidence.
2024-08-01 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation dated August 1, 2024, addressed to stock exchanges with scrip codes mentioned, indicating a regulatory filing context. It explicitly states it is an "Investors/Analysts Presentation" pursuant to SEBI regulations. The content includes detailed financial results for the quarter ended June 30, 2024 (Q1FY25), business highlights, management commentary, financial and operating metrics, and company overview. The document is about 15,000 characters long, which is substantial and contains detailed financial and strategic information typical of an investor presentation. There is no indication that this is a full annual or quarterly report, audit report, or earnings release summary. It is not a brief announcement or a certification letter. Therefore, the document fits the category of an Investor Presentation (IP).
2024-08-01 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter ended June 30, 2024, including key financial metrics such as total income, EBITDA, PAT, and EPS. It also mentions an upcoming earnings call to discuss the results. The document is dated August 1, 2024, and references Q1FY25 results, which corresponds to the first quarter of fiscal year 2025. The content is typical of an Earnings Release, providing initial highlights of quarterly financial performance without the full detailed financial statements or management discussion. Therefore, the document fits the definition of an Earnings Release (ER). Q1 2025
2024-08-01 English
Updates
Regulatory Filings
2024-08-01 English
Financial Result Updates
Regulatory Filings
2024-08-01 English
Shareholders meeting
Regulatory Filings
2024-07-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.